SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-042845
Filing Date
2018-11-09
Accepted
2018-11-09 16:02:48
Documents
75
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 1218910
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 317322
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 13913
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 14227
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7538
12 image0.jpg GRAPHIC 130471
13 image00001.jpg GRAPHIC 311512
14 image1.jpg GRAPHIC 265933
15 image2.jpg GRAPHIC 175452
16 image3.jpg GRAPHIC 169494
  Complete submission text file 0001140361-18-042845.txt   7798709

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rckt-20180930.xml EX-101.INS 984126
7 XBRL TAXONOMY EXTENSION SCHEMA rckt-20180930.xsd EX-101.SCH 54652
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20180930_cal.xml EX-101.CAL 50406
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20180930_def.xml EX-101.DEF 306338
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20180930_lab.xml EX-101.LAB 814354
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20180930_pre.xml EX-101.PRE 441070
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 181173065
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1